Quote:
Originally Posted by blackcat
I add it up like Martinello too.
<snip>
Where is the market? I just cannot see the market this big.
|
I don't know what the rest of the EPO market looks like, so it's hard to say. But I don't think that's the point. Unless I missed it, I didn't think anybody was saying that the pharma companies see elite athletes as an end market. The suggestion seems to be that they can be a useful source of guinea pigs during the drug development phase. That's an appealing argument, but I don't buy it.
I'm also very skeptical of conspiracy theories. BASIL asked how athletes got the drug before it was released. That's a good question, but are sure they did have it prior to release? In the US, Epogen/Procrit was first approved by the FDA for sale in 1989.